Etiket: Astrazeneca
AstraZeneca stock: AstraZeneca reports promising results for cancer drug Enhertu
To make it easier for you to keep track of the large number of messages that appear every day for a company, we have divided the news feed into the…
Outlook: AstraZeneca with figures for the past quarter
shares in this article AstraZeneca will present the quarterly figures for the most recent quarter – closing date June 30, 2022 – at the financial conference on July 29, 2022.…
AstraZeneca shares: AstraZeneca drugs Ultomiris and Tezspire receive approval recommendation in EU
shares in this article As announced by AstraZeneca, the European Medicines Agency’s Committee for Medicinal Products for Human Use bases its recommendation on the approval of the drug on the…
FACT CHECK. No, monkey pox has nothing to do with chimpanzee virus in AstraZeneca vaccine
Reports are surfacing on social media linking the monkeypox virus to the presence of a chimpanzee virus in the AstraZeneca vaccine. People are thus suggesting that the monkeypox virus might…
Authorized a trial of the Hipra vaccine for those vaccinated with AstraZeneca
The research will be carried out in parallel with the phase III trial that evaluates the safety of the vaccine as a booster dose of any of the already authorized…
AstraZeneca shares still burdened: AstraZeneca and Daiichi achieve study goal with cancer drug
shares in this article “Results from the Destiny-Breast04 series of trials demonstrate that Enhertu (trastuzumab deruxtecan) provides a statistically significant and clinically meaningful improvement in progression-free survival and overall survival…
RDIF announces the safety of a “cocktail” of AstraZeneca and Sputnik Light
Photo: Boris Roessler / TASS Tests of the combined use of AstraZeneca coronavirus vaccines as the first component and the Sputnik Light vaccine as the second showed the safety of…
Vaccine manufacturer Astrazeneca presents annual balance sheet
shares in this article CAMBRIDGE (dpa-AFX) – With the production of a corona vaccine and a multi-billion takeover, the pharmaceutical company AstraZeneca has had a turbulent year. The extent to…